$SOLV Balance Sheet | Understand Stock

$SOLV

$85.81 +$0.40 (0.47%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024
Assets
Current assets
Cash and cash equivalents
Accounts receivable — net of allowances of $82 and $87
Due from related parties
Inventories
Finished goods
Work in process
Raw materials and supplies
Total inventories
Other current assets
Current assets held for sale
Total current assets
Property, plant and equipment — net
Goodwill
Intangible assets — net
Other assets
Non-current assets held for sale
Total assets
Liabilities
Current liabilities
Short-term borrowings and current portion of long-term debt
Accounts payable
Due to related parties
Unearned revenue
Other current liabilities
Current liabilities held for sale
Total current liabilities
Long-term debt
Pension and postretirement benefits
Deferred income taxes
Finance leases
Other liabilities
Non-current liabilities held for sale
Total liabilities
Equity
Common stock, par value $0.01 per share, 750,000,000 shares authorized
Additional paid-in-capital
Retained earnings
Net parent investment
Treasury stock, at cost
Accumulated other comprehensive income (loss)
Total equity
Total liabilities and equity
Common stock issued (in shares)

Comments